Registration Links (4 Options)
ONC-ORG

Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy

NCT07467083 · Phase 3 · Chengdu, Sichuan, China

Recruiting
Condition
Head and Neck Cancer
Disease stage
Stage I-IV
Phase
Phase 3
Study type
BEHAVIORAL
Intervention
Nurse-led preemptive symptom management
Age
18 Years to 80 Years
Gender
All
Sponsor
West China Hospital
Research institution
West China Hospital
Facility
West China Hospital of Sichuan University
Research center
West China Hospital of Sichuan University

Summary

The aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models.

Detailed description

The aim of this study is to investigate whether a nurse-led preemptive symptom management protocol can reduce the radiation therapy interruption rate in patients with head and neck cancer compared to conventional care models. The secondary objective is to evaluate whether the nurse-led preemptive symptom management protocol improves symptoms, quality of life, and psychological well-being in head and neck cancer patients undergoing radiation therapy compared to conventional care models.

Inclusion criteria

1. Patients had pathologically confirmed malignant head and neck tumors without distant metastasis. 2. Patient age ≥18 years; Patients were scheduled to undergo either postoperative adjuvant radiotherapy or radical radiotherapy, with or without concurrent chemotherapy. 3. Baseline ECOG (Eastern Cooperative Oncology Group) score 0-2; 4. Good cognitive and reading skills, able to complete the questionnaire survey.

Exclusion criteria

1. Presence of other malignant tumors aside from head and neck malignancies; 2. A history of prior head and neck radiotherapy; 3. Mental illness or cognitive impairments; 4. Uncontrolled systemic diseases that could significantly affect their QoL.

Primary outcomes

Radiotherapy interruption rate

Secondary outcomes

Rehospitalization rate